FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Lupin Pharmaceuticals Telmisartan and Amlodipine Tablets 80 mg/5 mg Recall

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured…

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class III
Reported by FDA
Apr 17, 2019
Recall ID
D-1121-2019
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Telmisartan and Amlodipine Tablets 80 mg/5 mg starting Apr 1, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1121-2019 on Apr 17, 2019. Reason: Failed Impurities/Degradation Specifications; 18 month long term stability study. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; 18 month long term stability study.

Product description

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by : Lupin Limited, Goa, INDIA -- NDC 68180-198-06

Lot numbers, UPCs & expiration codes

G705843 Exp. date April, 2019 G707763 Exp. date August, 2019 G800434 Exp. date November, 2019

Where it was sold

Product was distributed to 6 wholesalers/ drug chains and 2 mail order pharmacies that may have further distribute the product throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1121-2019
Classification
Class III
Status
Terminated
Recall initiated
Apr 1, 2019
FDA report date
Apr 17, 2019
Quantity
12,504 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1121-2019, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
82528
Address
111 S Calvert St Fl 21ST
Code information
G705843 Exp. date April, 2019 G707763 Exp. date August, 2019 G800434 Exp. date November, 2019
Postal code
21202-6174
Report date
Apr 17, 2019
Product type
Drugs
Recall number
D-1121-2019
Classification
Class III
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
12,504 bottles
Termination date
Jul 1, 2020
Reason for recall
Failed Impurities/Degradation Specifications; 18 month long term stability study.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by : Lupin Limited, Goa, INDIA -- NDC 68180-198-06
Distribution pattern
Product was distributed to 6 wholesalers/ drug chains and 2 mail order pharmacies that may have further distribute the product throughout the United States.
Recall initiation date
Apr 1, 2019
Initial firm notification
Letter
Center classification date
Apr 11, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1121-2019, published Apr 17, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls